Asset Details
Do you wish to reserve the book?
Outcome of optic disc capillary hemangioma following intravitreal ranibizumab injection: A case report
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Outcome of optic disc capillary hemangioma following intravitreal ranibizumab injection: A case report
Do you wish to request the book?
Outcome of optic disc capillary hemangioma following intravitreal ranibizumab injection: A case report
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Outcome of optic disc capillary hemangioma following intravitreal ranibizumab injection: A case report
2025
Overview
Optic disc capillary hemangiomas, a rare capillary hamartoma that often invades optic nerve fibers and disc plaque bundles, have been a therapeutic challenge for ophthalmologists in recent years due to their unique location. A woman in her early 50s presented with blurred vision in the right eye for 2 days. On ocular examination, her best-corrected visual acuity was 20/340 in the right eye. Wide-field fundus imaging revealed a red mass on the temporal side of the optic disc. Optical coherence tomography revealed macular edema. The diagnosis was optic disc capillary hemangioma. Subsequently, 0.5 mg ranibizumab was intravitreally injected into the right eye once monthly, for a total of two injections. The patient was re-examined at 15 days, 50 days, and 21 months after the first operation. The patient’s postoperative best-corrected visual acuity improved to 20/60, and macular edema and exudation were reduced in the short term compared with those in the previous period; however, the tumor did not change significantly. The anti-vascular endothelial growth factor agent ranibizumab is effective in treating optic disc capillary hemangiomas.
Publisher
SAGE Publications,Sage Publications Ltd,SAGE Publishing
Subject
Angiogenesis Inhibitors - administration & dosage
/ Angiogenesis Inhibitors - therapeutic use
/ Edema
/ Female
/ Hemangioma, Capillary - diagnostic imaging
/ Hemangioma, Capillary - drug therapy
/ Hemangioma, Capillary - pathology
/ Humans
/ Macular Edema - drug therapy
/ Optic Disk - diagnostic imaging
/ Optic Nerve Neoplasms - drug therapy
/ Optic Nerve Neoplasms - pathology
/ Ranibizumab - administration & dosage
/ Ranibizumab - therapeutic use
